Hepatic Encephalopathy: Pathophysiology and Treatment: 22 (Experimental Biology and Medicine, 22) - Image 1

£164.03

Humana Hepatic Encephalopathy: Pathophysiology and Treatment: 22 (Experimental Biology and Medicine, 22)

Name: Hepatic Encephalopathy: Pathophysiology and Treatment: 22 (Experimental Biology and Medicine, 22)
Brand: Humana
Price: 164.03 GBP
Availability: InStock

Gastroenterology

This is the most expensive it has ever been. Walk away.

£164 today · previous high £164 · all-time low £164

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 64 days · 64 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 64 days • 1 price levels

Days at Price

Price Analysis

Most common price: £164 (64 days, 100.0%)

Price range: £164 - £164

Price levels: 1 different prices over 64 days

Description

Hepatic Encephalopathy (HE) is a neuropsychiatric disorder resul t ing from liver failure. HE may be associated with fulminant (acute) hepatic failure or chronic liver disease with portal-systemic shunting. The latter condition is characterized neuropathologically by astro cytic rather than neuronal changes (Alzheimer Type II astrocytosis). The former is frequently accompanied by cerebral edema. Several hypotheses have been proposed to explain the pathogene sis of HE. These include: 1. A toxic action of a substance (or substances) such as ammonia on brain function 2. A deficit of cerebral energy metabolism 3. Neurotransmitter changes, and, more recently 4. The role of "endogenous benzodiazepines. " This volume summarizes the results of a symposium held in Val David, Quebec from October 3D-November I, 1988, that was devoted to an evaluation of the evidence for and against the various hypothe ses of HE. Data from studies in patients, in experimental (animal) models of HE, and in cultured cell preparations were discussed. In addition, a review of available approaches to the treatment and man agement of HE was included. The therapeutic use of lactulose, anti biotics, dietary treatment, and branched-chain amino acid treatments were included, as well as the results of preliminary studies of the therapeutic use of the benzodiazepine antagonist, flumazenil. Roger F. Butterworth, PhD Gilles Pomier Layrargues, MD v Acknowledgments The symposium was made possible by the generous financial assistance of: Hoffman-La Roche Ltd.

Product Specifications

Brand: Humana
Format: paperback
ASIN: 1461288517
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Gastroenterology
Domain: Amazon UK
Publication Date: 17 September 2011
Listed Since: 21 December 2012

Barcode

No barcode data available

Humana Hepatic Encephalopathy: Pathophysiology and Treatment: 22 (Experimental Biology and Medicine, 22)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

1,000+ Practice Questions with Rationales for Psychiatric Technician Licensure Examination

Peripheral Benzodiazepine Receptors (Neuroscience Perspectives)

Benzodiazepine Receptor Ligands, Memory and Information Processing: Psychometric, Psychopharmacological and Clinical Issues: 6 (Psychopharmacology Series, 6)

Sleep, Benzodiazepines and Performance: Experimental Methodologies and Research Prospects: 1 (Psychopharmacology Series, 1)

BENZODIAZEPINE: Abuse & Therapeutic Uses, Pharmacology & Health Effects (Pharmacology - Research, Safety Testing and Regulation: Substance Abuse Assessment, Interventions and Treatment)

Benzodiazepine-Based Drug Discovery (Heterocyclic Drug Discovery)

Benzodiazepines and GHB: Detection and Pharmacology (Forensic Science and Medicine)

Wiley Privileged Structures in Drug Discovery - Chemistry Text

Lawesson’s Reagent in Heterocycle Synthesis

β-Carbolines: A Privileged Scaffold for Modern Drug Discovery

Structure–Activity Relationships for Development of Neurokinin-3 Receptor Antagonists: Reducing Environmental Impact (Springer Theses)

Metals and Non-metals: Five-membered N-heterocycle Synthesis

Cycloaddition Reactions: Advances in Research and Applications (Chemistry Research and Applications)

Raney Nickel-Assisted Synthesis of Heterocycles

Behavioral Neurobiology of GABAB Receptor Function: 52 (Current Topics in Behavioral Neurosciences, 52)

Oxadiazole in Material and Medicinal Chemistry

Depression and Anxiety: Prevalence, Risk Factors and Treatment

Strategies for Resolving Individual and Family Problems

The 2023-2028 Outlook for Benzodiazepine Drugs in the United States

Biological Reactive Intermediates Vi: Chemical and Biological Mechanisms in Susceptibility to and Prevention of Environmental Diseases: 500 (Advances in Experimental Medicine and Biology)

Springer - Staging Neuropsychiatric Disorders Book

Development of Tolerance and Dependence in Barbiturate Use

Poisoning and Drug Overdose, Eighth Edition

Biological Reactive Intermediates Vi: Chemical and Biological Mechanisms in Susceptibility to and Prevention of Environmental Diseases: 500 (Advances in Experimental Medicine and Biology, 500)